Items where authors include "Alivernini, S."

Article

Gremese, E., Alivernini, S., Tolusso, B. et al. (2 more authors) (2019) JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. Journal of Leukocyte Biology, 106 (5). pp. 1063-1068. ISSN 0741-5400